
Dr Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year
Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is a twice-yearly injection that was nearly…

Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is a twice-yearly injection that was nearly…

The refund amount includes interest of ₹8.89 crore, the company informed. Shares of New India Assurance Company Ltd ended at ₹195.50, down by ₹0.65, or…

Shares of Gujarat Pipavav Port Ltd ended at ₹153.25, down by ₹2.70, or 1.73%, on the BSE.

NSE CEO Ashishkumar Chauhan said SEBI will consider stakeholder views before any move on curbing weekly expiries, adding that initial volume impact would normalise over…

The subsidiary purchased 10.96 lakh compulsorily convertible preference shares and 16.44 lakh equity shares of the Mumbai-based textile company.

The investment involves 60 crore partly paid-up equity shares of face value ₹10 each, issued at par. Of this, ₹5 per share was paid on…

Between January 1 and September 24, 2025, the Sensex gained 3,577 points and the Nifty advanced 1,412 points, translating into a modest 5% return for…

The sellers in the transaction include promoter group members: Inder T. Jaisinghani, Ajay T. Jaisinghani, Ramesh T. Jaisinghani, Girdhari Thakurdas Jaisinghani, Bharat Jaisinghani, Nikhil Ramesh…

Polycab India promoters plan a ₹888 crore block deal, while Tata Steel invests ₹4,055 crore in its overseas arm TSHP. Piramal Enterprises gets NCLT nod…

The short-term trend remains negative, with Nifty sliding towards a crucial support zone near 24,900, analysts say.